Entrada Therapeutics

Business Services · Massachusetts, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

1 Design Center Pl Ste 17, Boston, Massa...

Phone Number

(857) 520-9158

Revenue

<$5 Million

Stock Symbol

TRDA

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
3
1
1
1
2
1

About Entrada Therapeutics

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases. Established in 2016, Entrada Therapeutics is headquartered in Boston, Massachusetts, United States.Explore more
Entrada Therapeutics's Social MediaPopular SearchesEntrada Therapeutics IncEntrada TherapeuticsEntradaSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: TRDAShow more

Entrada Therapeutics Org Chart

DD
United States flag for contact location.

Chief Executive Officer & Board Member

PhoneEmail
KW
United States flag for contact location.

Chief Financial Officer & Treasurer

PhoneEmail
Nathan Dowden, President & Chief Operating Officer at Entrada Therapeutics
United States flag for contact location.

President & Chief Operating Officer

PhoneEmail
NS
United States flag for contact location.

President, Research & Development

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
MB
United States flag for contact location.

Controller

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Entrada Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Entrada Therapeutics

Compare insights from companies similar to Entrada Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Entrada Therapeutics

<$5M
51-200
Public
$391M
2016
DD
Dipal DoshiCEO & Board Member
$232.4M
51-200
Public
$265.9M
2005
Eric Loumeau, Chief Legal Officer at AnaptysBio
Eric LoumeauChief Legal Officer
$31.3M
51-200
Private
-
2014
$26.4M
51-200
Private
$13.4M
2000
RS
Ruchi SinghalHead of Bioassay Development, Senior Group Leader
$18.3M
51-200
Private
-
2016
N/A
$13.9M
11-50
Private
-
-
N/A
$10.2M
51-200
Private
$225.1M
2017
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Entrada Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Entrada Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Entrada Therapeutics.

Entrada Therapeutics financials insights

Gather financial insights about Entrada Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2019

Other Financing Round

$34M

2020

Series A

$59M

2021

Series B

$116M

Stock Offering

$182M

See All Entrada Therapeutics's Financials Insights

Entrada Therapeutics Tech Stack

Most Recent Scoops

Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Open Position
Project
Pharmaceuticals, Clinical Operations
See more scoops

Top Business Services Companies

Frequently Asked Questions Regarding Entrada Therapeutics

What is Entrada Therapeutics's stock symbol?
Entrada Therapeutics's stock symbol is TRDA
What is Entrada Therapeutics's official website?
Entrada Therapeutics's official website is www.entradatx.com
What is Entrada Therapeutics's Revenue?
Entrada Therapeutics's revenue is <$5 Million
What is Entrada Therapeutics's SIC code?
Entrada Therapeutics's SIC: 87,873
What is Entrada Therapeutics's NAICS code?
Entrada Therapeutics's NAICS: 54,541
How many employees does Entrada Therapeutics have?
Entrada Therapeutics has 51-200 employees
What industry does Entrada Therapeutics belong to?
Entrada Therapeutics is in the industry of: Business Services, Research & Development
What is Entrada Therapeutics competition?
Entrada Therapeutics top competitors include: Plexium, World Preclinical Congress, LFB USA, Eurofins DiscoverX
What technology does Entrada Therapeutics use?
Some of the popular technologies that Entrada Therapeutics uses are: Cloudflare Website Optimization, Google Universal Analytics, Microsoft Azure, TIBCO Spotfire
Who is the CFO of Entrada Therapeutics?
Entrada Therapeutics's CFO is Kory Wentworth
How do I contact Entrada Therapeutics?
Entrada Therapeutics contact info: Phone number: (857) 520-9158 Website: www.entradatx.com
What does Entrada Therapeutics do?

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases. Established in 2016, Entrada Therapeutics is headquartered in Boston, Massachusetts, United States.... Read More

What are Entrada Therapeutics social media links?
Entrada Therapeutics Linkedin page Entrada Therapeutics Twitter page
Who invested in Entrada Therapeutics?
Entrada Therapeutics has 12 investors including MRL Ventures Fund, MPM Capital, Agent Capital and Roche.
Is Entrada Therapeutics a public company?
Yes, Entrada Therapeutics is a public company and is traded under the symbol TRDA
See more information about Entrada Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.